Project Grant K99NS149250
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $595,208 to The Regents of the University of California, San Francisco on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This five-year Project Grant, which extends through March 31, 2031, funds collaborative research investigating the cellular and circuit-level mechanisms underlying cognitive dysfunction and...
- Federal Project Grant Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Regents of the University of California, San Francisco a $238,680 Project Grant (CFDA 93.853: Extramural Research Programs in the Neurosciences and Neurological Disorders) on July 15, 2026, with completion targeted for June 30, 2031. The research project, "Dissecting Neural Circuits Regulating Sleep Fragmentation in Parkinson's Disease," investigates the neural mechanisms...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Regents of the University of California, San Francisco a $136,620 Project Grant effective February 1, 2026 through January 31, 2028, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This research project investigates the impact of pathological tau protein on neural circuit function in mouse models of progressive supranuclear...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded University of California, Los Angeles $407,739 on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This two-year project grant, extending through July 31, 2027, supports basic neuroscience research investigating the regulation of axon caliber in sensory neurons, with particular focus on the role of...
- Federal Project Grant Award Summary The University of California, San Diego received a $572,114 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 15, 2025, with a completion date of June 30, 2030. This research project focuses on developing and validating a novel therapeutic device and methodology for peripheral nerve repair...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a Project Grant of $1,180,687 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), with an award date of August 1, 2025, and completion date of July 31, 2033. This eight-year research initiative focuses on investigating the developmental transition of neural stem cell (NSC)...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $100,228 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on December 16, 2026, with completion targeted for August 31, 2028. The research initiative, titled "Cell-Type-Specific Contributions of Primary Somatosensory Cortex to Skilled...
- Federal Project Grant Summary The University of Georgia Research Foundation, Inc. received a $1.297 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded May 8, 2026, with completion targeted for April 30, 2029. The grant funds research into neuroinflammatory epitranscriptomic mechanisms in Parkinson's Disease, specifically investigating...
- Federal Project Grant Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Johns Hopkins University a $388,646 Project Grant effective June 16, 2026, through May 31, 2031, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research will investigate the molecular mechanisms of Delta-2 receptor (GluD2) dysfunction in neurological diseases, with particular focus on cerebellar ataxia, autism spectrum...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $150,932 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded March 1, 2026, with completion targeted for September 30, 2028. The grant funds theoretical neuroscience research investigating interactions between the motor cortex (M1) and dorsolateral...
Federal Project Grant Summary The University of California, San Francisco received a $117,747 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded July 7, 2026, with completion targeted for June 30, 2028. This grant supports basic neuroscience research investigating the functional roles of basal ganglia and cerebellar inputs to the motor thalamus in controlling gait and determining whether alterations in this circuit drive parkinsonian gait disturbances. The project addresses a significant clinical gap by examining how the motor thalamus integrates inputs from two major brain systems and regulates walking coordination through motor cortex connections—mechanisms implicated in gait disorders associated with Parkinson's disease and spinocerebellar ataxia. The research deliverables include quantitative kinematic and neurophysiological analyses using advanced experimental techniques including high-speed video gait analysis with machine learning-assisted tracking in freely walking mice, optogenetic identification and recording of single-unit thalamic neuron activity, and chemogenetic and optogenetic circuit perturbation studies. These technical approaches are designed to characterize gait-tuning properties of basal ganglia- and cerebellar-recipient thalamic neurons and establish causal relationships between motor thalamus circuit dysfunction and parkinsonian gait pathology, thereby advancing fundamental understanding of motor circuit organization relevant to treating neurological gait disorders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $117.7k | 7/7/26 |